2013年2月10日のブログで紹介した多発性硬化症の治療薬 Alemtuzumab承認に黄信号です。やはり副作用がネックのようです。

FDA staff raise safety concerns over Sanofi MS drug Lemtrada

Fri Nov 8, 2013 9:16am EST

Nov 8 (Reuters) – U.S. regulatory officials raised concerns about “multiple serious and potentially fatal safety issues” in patients given Sanofi’s new multiple sclerosis drug Lemtrada, raising concerns over its approval.

Shares in Sanofi fell 2 percent after the documents were posted on the FDA’s website on Friday.

(2013.11.14追記)

今度は「FDA panel supports approval of Sanofi MS drug Lemtrada」のニュース。迷走してます。

Tweet